	endotronics endo expects loss for year endotronics inc said it expects to incur substantial losses for the second quarter ending march and fiscal year ending sept as one factor behind the anticipated loss endotronics cited a dispute by one of its japanese distributors yamaha inc over payment of a dlr promissory note in a form k filing with the securities and exchange commission endotronics said the note was for overdue accounts receivable from sales of instruments to yamaha and another japanese distributor during the company s fiscal year endotronics said at its present reduced level of operations it will exhaust all currently available cash and credit facilities in early may it said this assumes full use of the remaining dlrs available under a line of credit from celanese corp which requires approval of celanese corp cz the company said its ability to obtain funding was adversely affected by a suit filed march by two of its shareholders seeking to represent a class of holders against three officers of endotronics endotronics said the complaint against it alleges violations of the federal securities laws in connection with statements made in the company s annual and quarterly reports the company also said the securities division of the minnesota department of commerce is conducting an inquiry into the company s japanese sales for fiscal and trading by insiders and brokers in the company s common shares it said similar inquiries are being conducted by the securities and exchange commission the investigations will hurt the company s ability to obtain funding it said as a result of the dispute over payment of the promissory note the law suit challenging its financial data and the various investigations concerning insider trading the company said it no longer expects that anticipated declines in instrument sales in japan in fiscal will be offset by increased instrument sales in other foreign countries and the united states reuter 
